Citius Pharmaceuticals, Inc.Citius Pharmaceuticals, Inc.Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

5.000.000.00%
The 2 analysts offering 1 year price forecasts for CTXR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to CTXR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CTXR EPS for the last quarter is −0.06 USD despite the estimation of −0.05 USD. In the next quarter EPS is expected to reach −0.05 USD. Track more of Citius Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Citius Pharmaceuticals, Inc. revenue is expected to reach 0.00 USD. Check out Citius Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, CTXR price target is 5.00 USD with a max estimate of 6.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Citius Pharmaceuticals, Inc. stock price chart and keep track of the current situation with CTXR news and stock market news.